dinitrochlorobenzene has been researched along with Leucocythaemia in 4 studies
Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with Hodgkin's disease tend to have depressed responses to both newly encountered and recall antigens." | 2.35 | Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. ( Burdick, JF; Herberman, RB; Wells, SA, 1975) |
| "Testing of delayed hypersensitivity responses to recall antigens, newly encountered antigens and tumor antigens has contributed to the understanding of several immunologic factors in human neoplasia." | 2.35 | Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. ( Burdick, JF; Herberman, RB; Wells, SA, 1975) |
| "Patients with solid tumors are more likely to be deficient only in the response to newly encountered antigens." | 2.35 | Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. ( Burdick, JF; Herberman, RB; Wells, SA, 1975) |
| "In acute non-lymphocytic leukemia (ANLL) patients, the 50% survival durations were 11 months in the PPD positive group and 6 months in the PPD negative group." | 1.26 | The relationship of cellular immunity to prognosis in acute leukemia. ( Chen, P; Kitajima, K; Naito, T; Nakanishi, N; Takahashi, I; Takahashi, Y; Toki, H, 1977) |
| "The concepts that human tumors elicit cell-mediated immune responses to tumor antigens are re-examined and modified; for example, cell-mediated immunity may be detectable only at certain stages of tumor growth." | 1.26 | Immunotherapy and human tumor immunology. ( Brosman, S; Fahey, JL; O'Toole, C; Ossorio, RC; Zighelboim, J, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burdick, JF | 1 |
| Wells, SA | 1 |
| Herberman, RB | 1 |
| Toki, H | 1 |
| Takahashi, Y | 1 |
| Nakanishi, N | 1 |
| Naito, T | 1 |
| Chen, P | 1 |
| Takahashi, I | 1 |
| Kitajima, K | 1 |
| Fahey, JL | 1 |
| Brosman, S | 1 |
| Ossorio, RC | 1 |
| O'Toole, C | 1 |
| Zighelboim, J | 1 |
| Witherspoon, RP | 1 |
1 review available for dinitrochlorobenzene and Leucocythaemia
| Article | Year |
|---|---|
Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
Topics: Antigens; Antigens, Neoplasm; Arthus Reaction; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Coloni | 1975 |
3 other studies available for dinitrochlorobenzene and Leucocythaemia
| Article | Year |
|---|---|
The relationship of cellular immunity to prognosis in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Dinitrochlorobenzene; Female; Humans; Immunity, Cellular; Le | 1977 |
Immunotherapy and human tumor immunology.
Topics: BCG Vaccine; Dinitrochlorobenzene; Immunity, Cellular; Immunotherapy; Leukemia; Neoplasms; Propionib | 1976 |
Suppression and recovery of immunologic function after bone marrow transplantation.
Topics: Adult; Age Factors; Aged; Bone Marrow Transplantation; Dinitrochlorobenzene; Graft vs Host Disease; | 1986 |